NEW YORK (GenomeWeb News) – A collection of London research institutes and hospitals have banded together to launch an initiative to develop genetically tailored treatments for thousands of lung cancer patients, the Institute for Cancer Research said today.

The partners involved in the new London Lung Cancer Alliance plan to use tumor sequencing and genetic testing to personalize treatments for up to 3,000 lung cancer patients a year in London and in five other cities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.